These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8436074)

  • 1. [Organ-preserving therapy of invasive bladder carcinoma].
    Sauer R; Dunst J
    Dtsch Med Wochenschr; 1993 Feb; 118(6):205. PubMed ID: 8436074
    [No Abstract]   [Full Text] [Related]  

  • 2. Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
    Zietman AL; Shipley WU; Kaufman DS; Esrig D; Lytton B
    Contemp Urol; 1995 Jul; 7(7):23-4, 29, 32, passim. PubMed ID: 10150577
    [No Abstract]   [Full Text] [Related]  

  • 3. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
    Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
    BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of preserving therapy of invasive cancer of the urinary bladder].
    Matveev BP; Sallum SD; Kamolov BSh; Figurin KM; Matveev VB; Volkova MI
    Urologiia; 2005; (6):3-6. PubMed ID: 16419470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of radiotherapy in bladder-preserving cancer therapy?
    Rödel C; Sauer R
    Nat Clin Pract Oncol; 2005 Jan; 2(1):4-5. PubMed ID: 16264831
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
    Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
    Choueiri TK; Raghavan D
    Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Lin CC; Hsu CH; Cheng JC; Huang CY; Tsai YC; Hsu FM; Huang KH; Cheng AL; Pu YS
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):442-8. PubMed ID: 19307067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
    Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Organ-preserving therapy of muscle-invasive bladder carcinoma].
    Hartung R; Block T
    Dtsch Med Wochenschr; 1992 Nov; 117(47):1818. PubMed ID: 1425310
    [No Abstract]   [Full Text] [Related]  

  • 14. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
    Heidenreich A
    Eur Urol; 2008 Jul; 54(1):21-3. PubMed ID: 18262722
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of organ-preserving therapy for invasive bladder cancer].
    Matveev BP; Figurin KM; Toktomushev AT
    Urologiia; 2002; (3):3-5. PubMed ID: 12180056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New developments in the treatment of muscle-invasive bladder cancer].
    Kerst JM; Pos FJ; Visser O; Horenblas S
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):187-92. PubMed ID: 18320942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined therapy for patients with invasive bladder cancer].
    Startsev VIu; Karelin MI
    Vopr Onkol; 2003; 49(2):235-8. PubMed ID: 12785212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.